KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. (KLDO) Stock Price, Quote, News & History

Key Statistics

Open

Volume / Avg.

0 / 2.17K

Day Range

- - -

52 Wk Range

0.00 - 0.35

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

51.9

Recent Kaleido Biosciences Inc News

The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More

Biotech stocks retreated in the week ending April 14, lock-stepping with the broader market. The news flow was light during the holiday-shortened week and ahead of the imminent first-quarter reporting season.

Shanthi Rexaline

Kaleido Biosciences Shares Plunging To 52-Week Low, Read Why

Vandana Singh

Kaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target

Kaleido Biosciences Inc (NASDAQ: KLDO) halted work on a planned phase 2 trial in chronic obstructive pulmonary disease (COPD) and

Vandana Singh

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7)

Shanthi Rexaline

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6)

Shanthi Rexaline

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-77.09M

Investing Cash Flow (TTM)

-691.00K

Financing Cash Flow (TTM)

70.04M

Free Cash Flow (TTM)

-78.22M

Capital Expenditure (TTM)

-1.13M

Net Change in Cash (TTM)

-7.75M

Valuation Metrics

Enterprise Value

-$16.78M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$21.69M

LT Debt

$5.55M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$38.47M

Debt to Equity

2.05

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 2.17K

Day Range

- - -

52 Wk Range

0.00 - 0.35

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

51.9

About

Sector

Health Care

Industry

Pharmaceuticals

Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

KLDO

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

KLDO

FAQ

How do I buy KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. (KLDO) stock?

You can purchase shares of KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. (OTCEM:KLDO) through any online brokerage.

View our list of the best stock brokerages

Who are KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. (KLDO) competitors?

There are no as such competitors for KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc..

What is the forecast, or price target, for KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. (KLDO) stock?

There is no analysis for KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. to provide a consensus price target.

What is the current price for KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. (KLDO)?

The stock price for KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. (OTCEM: KLDO) is $0.000001 last updated August 26, 2026 at 4:00 PM EDT.

Does KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. (KLDO) pay a dividend?

There are no upcoming dividends for KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc..

When is KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. (OTCEM:KLDO) reporting earnings?

KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. does not have any upcoming earnings scheduled.

Is KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. (KLDO) going to split?

There is no upcoming split for KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc..

What sector and industry does KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. (KLDO) operate in?

KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.